First human test for new cancer drug combo begins
Disease control
Recruiting now
This is a first-in-human study to check the safety and find the right dose of a new drug, KGX101, given alone or with another cancer drug called envafolimab. It involves about 57 Chinese patients with advanced solid tumors that have not responded to standard treatments. The main …
Phase: PHASE1 • Sponsor: Kangabio AUSTRALIA LTD PTY • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC